Can biosimilars help achieve the goals of US health care reform?

Por Boccia, Ralph, Jacobs, Ira, Popovian, Robert, de Lima Lopes, Gilberto
Publicado no Cancer Manag Res (2017)

Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis

Por Simoens, Steven, Jacobs, Ira, Popovian, Robert, Isakov, Leah, Shane, Lesley G.
Publicado no Pharmacoeconomics (2017)

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Por Dranitsaris, George, Jacobs, Ira, Kirchhoff, Carol, Popovian, Robert, Shane, Lesley G
Publicado no Clinicoecon Outcomes Res (2017)

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Por Cohen, Hillel, Beydoun, Donna, Chien, David, Lessor, Tracy, McCabe, Dorothy, Muenzberg, Michael, Popovian, Robert, Uy, Jonathan
Publicado no Adv Ther (2016)